Jundishapur Journal of Microbiology

Published by: Kowsar

The Frequency and Typing of Human Papilloma Virus Among Women with Normal and Abnormal Cytology in Southern Khorasan, Eastern Iran

Davod Javanmard 1 , Mohammad Hasan Namaei 1 , * , Fatemeh Haghighi 2 , Masood Ziaee 1 , Mahmoodreza Behravan 1 , Jamal Mirzaei 3 , Nahid Ghanbarzadeh 4 , Zohreh Khazaei 4 , Mahboobeh Zangoie 4 , Narges Naseh 4 , Marzieh Ataei 4 , Gholamreza Sharifzadeh 1 , Alireza Salehabadi 1 and Malaknaz Ghannadkafi 5
Authors Information
1 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Department of Pathology, Birjand University of Medical Sciences, Birjand, Iran
3 Infectious Disease Research Center, Aja University of medical sciences, Tehran, Iran
4 Department of Gynecology, Birjand University of Medical Sciences, Birjand, Iran
5 Faulty of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Jundishapur Journal of Microbiology: April 2017, 10 (4); e43213
  • Published Online: March 6, 2017
  • Article Type: Research Article
  • Received: October 19, 2016
  • Revised: February 7, 2017
  • Accepted: February 26, 2017
  • DOI: 10.5812/jjm.43213

To Cite: Javanmard D, Namaei M H, Haghighi F, Ziaee M, Behravan M, et al. The Frequency and Typing of Human Papilloma Virus Among Women with Normal and Abnormal Cytology in Southern Khorasan, Eastern Iran, Jundishapur J Microbiol. 2017 ; 10(4):e43213. doi: 10.5812/jjm.43213.

Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Organization WH. .
  • 2. Akyar I, Aydin Ö, Yakicier MC, KocagÖZ ZT, İNce Ü, ÜNsal İ. Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turkish J Med Sci. 2013; 43: 963-70[DOI]
  • 3. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002; 55(4): 244-65[DOI][PubMed]
  • 4. Chung CH, Bagheri A, D'Souza G. Epidemiology of oral human papillomavirus infection. Oral Oncol. 2014; 50(5): 364-9[DOI][PubMed]
  • 5. Klug SJ, Hukelmann M, Hollwitz B, Duzenli N, Schopp B, Petry KU, et al. Prevalence of human papillomavirus types in women screened by cytology in Germany. J Med Virol. 2007; 79(5): 616-25[DOI][PubMed]
  • 6. Daneshvar F, Haghshenas M, Majleci F, Rahimi A. The prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology in north of Iran. Jundishapur J Microbiol. 2016; 10(1)[DOI]
  • 7. Roush SW, McIntyre L, Baldy LM. Manual for the surveillance of vaccine-preventable diseases. 2008;
  • 8. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6): 518-27[DOI][PubMed]
  • 9. Giuliano AR, Nyitray AG, Kreimer AR, Pierce Campbell CM, Goodman MT, Sudenga SL, et al. EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer. 2015; 136(12): 2752-60[DOI][PubMed]
  • 10. Hegde D, Shetty H, Shetty PK, Rai S, Manjeera L, Vyas N, et al. Diagnostic value of VIA comparing with conventional Pap smear in the detection of colposcopic biopsy proved CIN. Nepal J Obstet Gynaecol. 2011; 6(1): 7-12
  • 11. Nanda K, McCrory DC, Myers ER, Bastian LA, Hasselblad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000; 132(10): 810-9[DOI][PubMed]
  • 12. Chao A, Hsu KH, Lai CH, Huang HJ, Hsueh S, Lin SR, et al. Cervical cancer screening program integrating Pap smear and HPV DNA testing: a population-based study. Int J Cancer. 2008; 122(12): 2835-41[DOI][PubMed]
  • 13. Das BC, Murthy NS, Sharma JK, Singh V, Sehgal A, Gopalkrishna V, et al. Human papillomavirus and cervical cancer in indian women. Lancet. 1989; 334(8674): 1271[DOI]
  • 14. Arora R, Kumar A, Prusty BK, Kailash U, Batra S, Das BC. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur J Obstet Gynecol Reprod Biol. 2005; 121(1): 104-9[DOI][PubMed]
  • 15. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, Hammouda D, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004; 111(2): 278-85[DOI][PubMed]
  • 16. Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine. 2008; 26 Suppl 10-16[DOI][PubMed]
  • 17. Nobre RJ, de Almeida LP, Martins TC. Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm. J Clin Virol. 2008; 42(1): 13-21[DOI][PubMed]
  • 18. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer cells. 1989; 7(17): 209-14
  • 19. Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990; 71 ( Pt 1): 173-81[DOI][PubMed]
  • 20. Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007; 85(9): 719-26[DOI][PubMed]
  • 21. Wani K, Nair C. Genetic alterations in cervical cancer. Indian J Exp Biol. 2003; 41(8): 789-96
  • 22. Castellsague X, Munoz N. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr. 2003; 2003(31): 20-8[DOI]
  • 23. Kabat GC, Miller AB, Jain M, Rohan TE. Dietary intake of selected B vitamins in relation to risk of major cancers in women. Br J Cancer. 2008; 99(5): 816-21[DOI][PubMed]
  • 24. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med. 2002; 347(21): 1645-51[DOI][PubMed]
  • 25. Khorasanizadeh F, Hassanloo J, Khaksar N, Mohammad Taheri S, Marzaban M, H. Rashidi B , et al. Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature. Gynecol Oncol. 2013; 128(2): 277-81[DOI][PubMed]
  • 26. Moradi A, Bakhshandeh Nosrat S, Besharat S. Molecular Epidemiology of High-Risk Types of Human Papillomaviruses (16, 18) in Pap-Smear, the North East of Iran. Iran J Cancer Prev. 2011; 4(3): 135-40[PubMed]
  • 27. Mohseni Mehran SM, Mansour Ghanaei M, Mojtehadi A. The prevalence of human papilloma virus (HPV) in women using liquid base pap smear in Rasht, northern of Iran. J Clin Diagn Res. 2015; 9(7)-2[DOI][PubMed]
  • 28. Malary M, Moosazadeh M, Hamzehgardeshi Z, Afshari M, Moghaddasifar I, Afsharimoghaddam A. The prevalence of cervical human papillomavirus infection and the most at-risk genotypes among Iranian healthy women: A systematic review and meta-analysis. Int J Prev Med. 2016; 7[DOI]
  • 29. Salehi-Vaziri M, Sadeghi F, Hashemi FS, Haeri H, Bokharaei-Salim F, Monavari SH, et al. Distribution of human papillomavirus genotypes in Iranian women according to the severity of the cervical lesion. Iran Red Crescent Med J. 2016; [DOI]
  • 30. Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012; 285(3): 771-7[DOI][PubMed]
  • 31. Shafaghi B, Jarollahi A, Yousefzadeh B, Ameri A, Moghadam S, Mostafavi M. Human papilloma virus prevalence and types among Iranian women attending regular gynecological visits. Rep Radiother Oncol. 2013; 1(2): 73-9
  • 32. Afshar RM, Mollaie HR, Fazlalipour M, Arabzadeh SA. Prevalence and type distribution of human papillomavirus infection using the INNo-Lipa assay, Kerman, Southeast Iran. Asian Pac J Cancer Prev. 2013; 14(9): 5287-91[DOI][PubMed]
  • 33. Salehi-Vaziri M, Sadeghi F, Bokharaei-Salim F, Younesi S, Alinaghi S, Monavari SH, et al. The prevalence and genotype distribution of human papillomavirus in the genital tract of males in Iran. Jundishapur J Microbiol. 2015; 8(12)[DOI]
  • 34. Jalilvand S, Shoja Z, Nourijelyani K, Tohidi HR, Hamkar R. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination. J Med Virol. 2015; 87(2): 287-95[DOI][PubMed]
  • 35. Zandi K, Eghbali SS, Hamkar R, Ahmadi S, Ramedani E, Deilami I, et al. Prevalence of various human papillomavirus (HPV) genotypes among women who subjected to routine Pap smear test in Bushehr city (south west of Iran) 2008-2009. Virol J. 2010; 7: 65[DOI][PubMed]
  • 36. Terai M, Burk RD. Complete nucleotide sequence and analysis of a novel human papillomavirus (HPV 84) genome cloned by an overlapping PCR method. Virology. 2001; 279(1): 109-15[DOI][PubMed]
  • 37. Widdice LE, Breland DJ, Jonte J, Farhat S, Ma Y, Leonard AC, et al. Human papillomavirus concordance in heterosexual couples. J Adolesc Health. 2010; 47(2): 151-9[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments